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Relationship of Aluminum to Alzheimer's
Disease
by Daniel P. Perl*
Alzheimer's disease is a progressive degenerative brain disease of unknown etiology, characterized by
the development of large numbers of neurofibrillary tangles and senile plaques in the brain. Aluminum
salts may be used experimentally to produce lesions which are similar, but not identical, to the neurofi-
brillary tangle. Although some studies have reported increased amounts of aluminum in the brains of
Alzheimer's disease victims, these bulk analysis studies have been difficult to replicate and remain con-
troversial. Usingscanningelectron microscopy withX-ray spectrometry, we have investigatedthisquestion
on the cellular level. We have identified abnormal accumulations of aluminum within neurons derived
from Alzheimer's disease patients containing neurofibrillary tangles. Similar accumulations have been
detected in the numerous neurofibrillary tangle-bearing neurons seen in the brains ofthe indigenous native
population of the island of Guam who suffer from amyotrophic lateral sclerosis and parkinsonism with
dementia. Epidemiologic evidence strongly suggests a causal role for local environmental conditions
relatingtoavailabilityofaluminum, calcium, andmagnesium. Inviewofthefactthatamajorconsequence
of acid rain is the liberation of large amounts of aluminum in bioavailable forms, concerns are raised
about possible human health risks of this environmental phenomenon.
Introduction
Despite the fact that the histologic and clinical fea-
tures ofAlzheimer's disease have been documented and
extensively studied over the past century, we still do
not have a clear concept of this disorder's etiology or
pathogenesis. For the neuropathologist, Alzheimer's
disease is a condition that is characterized clinically by
progressive cognative dysfunction and pathologicallyby
thedevelopmentoflargenumbers ofneurofibrillarytan-
gles and senile or neuritic plaques in the neocortex and
hippocampus (1). Alzheimer's disease represents a pro-
gressive degenerative disease of the central nervous
system of unknown etiology.
In our laboratory, we have studied the potential role
of aluminum in the pathogenesis of the neurofibrillary
tangle, an important component in the histologic
changes seen in Alzheimer's disease. In this paper, we
will discuss the association of aluminum to Alzheimer's
disease and to other conditions in which neurofibrillary
tangles are encountered, as well as the data, both for
and against, ofacausal linkrelated to the neurotoxicity
ofthis element. Finally, we will discuss the implications
of changes in geochemistry and ecosystems associated
withacidrain, andtheirpotentialimplicationstoaltered
risks for aluminum neurotoxicity.
*Department ofPathology, University ofVermont College ofMed-
icine, Burlington, VT.
Aluminum and Alzheimer's Disease
The potential association of aluminum and Alz-
heimer's disease began with observations made in 1965,
by Klatzo and co-workers (2) and by Terry and Penia
(3), ofthe experimental induction ofneurofibrillary de-
generation in rabbits following exposure of the central
nervous system to aluminum salts. These workers and
others (4,5) have described prominent, widespread,
neurofilamentous accumulations which developed in
neuronal perikarya following the introduction of alu-
minum salts directly onto the central nervous system
parenchyma or into the cerebrospinal fluid. These ex-
perimentally induced neurofilamentous changes were
orignally considered to be comparable to human neu-
rofibrillary tangles.
However, criticism soon began to be raised concern-
ing the use of the aluminum-induced neurofilamentous
accumulations as an experimental model of the human
neurofibrillarytangle (3,6). Atthetime, thehuman neu-
rofibrillary tangle was considered by most workers in
the field to be an altered neurotubule (the so-called
twisted tubule) (7), whereas the aluminum-induced tan-
gles were composed of straight neurofilaments. Sub-
sequent investigation ofthis issue led to the acceptance
ofthe concept ofthe human neurofibrillary tangle being
composed of a pair of helically wound neurofilaments
(8,9), the so-called paired-helical filament, thus provid-10D. P. PERL
ing a closer link to the aluminum model.
Currently, unresolved issues exist related to shared
versus separateantigenicdeterminants betweennormal
neurofflaments and paired helical filaments (10-14). At
present, mechanisms for the formation of the unique
paired helical configuration ofthe cytoskeletal elements
seen in man's neurofibrillary tangle are not clearly es-
tablished. Although the precise biochemical nature of
the subunits ofthe paired helical filaments is currently
uncertain, structural and antigenic evidence exists
which suggests that an altered neurofilament is a likely
candidate (15-17). An inherent resistance ofthe paired-
helical filaments to become solubilized following harsh
proteolytic treatment has significantly hampered prog-
ress in this field (14). Until the nature ofthe basic com-
ponents ofthe paired helical filaments are known, along
with the mechanism for its unique structural configu-
ration, not encountered naturally or experimentally, in
animals other than man, these concerns will remain un-
resolved.
The existence of the rabbit animal model stimulated
Crapper-McLachlan and colleagues to investigate the
aluminum content ofbrain tissues ofpatients with Alz-
heimer's disease. These workers reported (18,19) sig-
nificantly increased levels of brain aluminum content,
particularly in those regions of the brain containing
large numbers of neurofibrillary tangles. Crapper-
McLachlans' workhas been difficult toreplicate and this
subject remains controversial (20-22). All ofthese stud-
ies employ assay techniques which are inherently tissue
destructive (atomic absorption spectrometry and neu-
tron activation analysis) and also require relatively
large bulk samples. In a situation offocal accumulations
ofan element in association with certain cellular lesions,
dilution ofthe element ofinterest within the relatively
large total sample being analyzed may result in an in-
ability to detect significant differences between affected
tissues and uninvolved controls.
Scanning Electron Microscopy-
X-Ray Spectrometry Studies
In ourlaboratory, we have developed highly sensitive
techniques, through the use of scanning electron mi-
croscopy in conjunction with energy dispersive x-ray
spectrometry, for the analysis oftrace element constit-
uents ofthe nervous system at the cellular level of res-
olution (23-25). Thetissues beinganalyzed are prepared
as frozen sections offormalin fixed brain samples. Cells
of interest are located through examination of the sec-
ondary electron surface images or the appearance of
back-scattered electron images obtained from silver-
stained sections. The electron beam is then focussed to
approximately one micron in diameter and this minute
portion of the section is irradiated with electrons, pro-
ducing X-rays. The X-rays that are emitted are char-
acteristic in their energy levels for the elements con-
tained within the portion of the tissue being hit by the
electron beam. By collecting and analyzing the X-rays
emitted from selected portions of individual neurons,
we can provide information about elemental content
with rather precise cellular localization.
Using these techniques, we have identified intraneu-
ronal accumulations of aluminum in association with
neurofibrillarytangle formationinthe hippocampal neu-
rons of brain tissues obtained from patients with Alz-
heimer's disease (23,26). Adjacent tangle-free neurons
ofthese cases, orofage-matched controls, failedto show
a similar degree of intraneuronal aluminum accumula-
tion. The aluminumaccumulations appeartobe confined
to the nuclear region of the cell and are not found in
the perikaryal cytoplasm, the neurofibrillary tangle it-
self, or the adjacent neuropil.
Studies of High-Risk Foci
Although a pathologic hallmark of Alzheimer's dis-
ease, neurofibrillary tangles are found in association
with a wide variety of other neurologic disorders (27).
In an attempt further to evaluate intraneuronal alu-
minumcontent in association with neurofibrillary tangle
formation, we have studied the remarkable tendency
towards the development of this form of neuronal pa-
thology shown by the Chamorro people native to the
island of Guam. This group of indigenous natives show
an inordinately high tendency to develop certain neu-
rodegenerative disorders; namely, a form ofparkinson-
ism associated with severe dementia and amyotrophic
lateral sclerosis (ALS). Neuropathologic examination of
the brains of parkinsonism with dementia cases from
Guam shows a profound loss ofthe pigmented neurons
of the substantia nigra as well as severe widespread
neurofibrillary tangle formation (28). The central ner-
vous systemofcasesofALS from Guamshowthe classic
features of motor neuron degeneration as well as ex-
tensive neurofibrillary tangle formation, a feature
rarely encountered in cases of ALS seen elsewhere in
the world (29,30).
In collaboration with the NIH-Laboratory ofCentral
Nervous System Studies, we have been engaged in the
study of the trace element constituents of the tangle-
bearing neurons encountered in the Chamorro natives
of Guam. Using our scanning electron microscopy-
X-ray spectrometry probe techniques, we have clearly
demonstrated that aluminum selectively accumulates
within the tangle-bearing neurons of the Guamanian
native affected with parkinsonism-dementia and ALS
(26,31). The aluminum-related X-rays generated from
probe sites ofthe tangle-bearing neurons ofthese cases
were3-4timesgreaterthanthose obtainedfromtangle-
free Guamanian control specimens. The dramatic ac-
cumulation of aluminum in the tangle-bearing neurons
of the Guamanian Chamorro has recently been inde-
pendently confirmed using a different X-ray spectro-
metry imaging approach (32).
Table 1 provides data related to X-ray probe sites
taken on tangle-bearing and tangle-free hippocampal
neurons of cases of Alzheimer's disease, Guamanian
ALS and parkinsonism-dementia and appropriate con-
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Table 1. Aluminum-related x-rays collected from hippocampal neurons.
X-ray counts (± 1 SE)
Neurofibrillary Adjacent
Case Age, yr tangles Nuclear region Perikaryal cytoplasm neuropil
Alzheimer's Disease 88 + 160.5 ± 14.3 118.5 ± 23.1 48.6 ± 14.0
Alzheimer's Disease 83 + 168.9 ± 14.8 104.6 ± 16.6 27.8 ± 11.7
U.S. control 88 - 75.8 ± 11.9 65.3 ± 12.8 86.8 ± 30.0
U.S. control 82 - 64.9 ± 12.1 89.4 ± 14.4 61.8 ± 33.0
Guam ALS 67 + 299.1 ± 28.7 330.4 ± 30.4 179.1 ± 43.8
Guam PD 66 + 232.1 ± 23.8 226.8 ± 34.6 99.4 ± 24.1
Guam control 48 - 106.8 ± 17.4 117.9 ± 17.4 109.3 ± 29.4
Guam control 65 - 100.9 ± 17.2 90.1 ± 14.4 60.3 ± 14.8
trols. The sections were cut on a cryostat at 20 ,um from
blocks of formalin-fixed tissue. The sections were
mounted unstained on pure carbon stubs, air-dried, and
lightly carbon coated. Regions ofthe hippocampus with
numerous tangle-bearing neurons were identified in se-
rially cut sections which were stained with the Biel-
schowsky silver technique and viewed by light micros-
copy. Using identical conditions of specimen
preparation, X-ray generation and data collection, 20
neurons from the CA1 region ofthe hippocampus were
subjected to multipoint X-ray probe analysis. The data
provided gives the aluminum-related X-ray counts (±
1 S.E.) following computer-assisted background sub-
traction within a 150-eV window centered around the
K-alpha of aluminum.
It should be pointed out that these techniques permit
us to simultaneously evaluate several other elements
within the tissues being probed. In these studies, alu-
minum represents the only element which is consist-
ently altered in relationship to the presence, in a neu-
ron, ofa neurofibrillary tangle. Many ofthe cases have
shown increased calcium-related X-ray signals in the
tangle-bearingneurons (26). Some cases, however, have
failed to demonstrate a similar accumulation. In con-
trast tothe tightly bound nature ofthe aluminum, much
ofintracellular calcium is lost following the death ofthe
individual and in the fixation of the specimen. Accord-
ingly, we are presently unable to fully interpret the
calcium-related data.
Over the past 35 years, research interest in the phe-
nomenon ofneurodegenerative disease ofepidemic pro-
portions among the Guamanian natives has centered
primarily on attempts to determine the underlying
mechanismsresponsibleformotorneurondegeneration.
As D. Carleton Gajdusek has written (33), "Discovery
ofits cause and pathogenesis in these intensely affected
populations will surely contribute to a better under-
standing of the disease (ALS) elsewhere." It has been
our belief that the remarkable tendency of the natives
living on Guam to develop large numbers of neurofi-
brillary tangles represents a similar opportunity with
respect to Alzheimer's disease.
Evaluation of a large amount of epidemiologic evi-
dence strongly suggests that certain environmental fac-
tors may play an important etiologic role in the neu-
rodegenerative phenomena so prevalent on Guam
(34,35). Important in this consideration are observa-
tions made of two additional foci in the western Pacific
both ofwhich show a similar high incidence ofALS and
parkinsonism-dementia, that is, the Kii peninsula of
southern Japan (36) and the Auyu and Jakai people of
southwestern New Guinea (37). Careful evaluation of
these populations fails to reveal shared genetic consti-
tuencies and environmental factor/s common to all three
high-risk foci have been sought.
It has been noted that all three areas have an alu-
minum-rich bauxite soil in association with markedly
low levels ofcalcium and magnesium in the local garden
soil and water supplies (38,39). Until recently, all three
foci remained isolated with extremely limited access to
imported foodstuffs. It is of particular interest that,
over the past two decades, Guam has witnessed a dra-
matic drop in the incidence of both ALS and parkin-
sonism-dementia (40). Indeed, instead ofhaving a fifty-
fold higher risk ofdeveloping ALS, as existed 30 years
ago, the Guamanian Chamorro now has a risk that is
only a few times higher than that ofthe U.S. resident.
It is unclear whether this dramatic change in incidence
data is related to the coincident influx, duringthis same
period oftime, of many ofthe commercial products as-
sociated with "westernization." However, there can be
virtually no doubt that this relatively abrupt change in
incidence strongly suggests that the environment plays
an important causal role in these phenomena.
Aluminum, Alzheimer's Disease and
the Environment
It is difficult to speculate on the implications of the
data obtained from the Guam focus to an understanding
ofAlzheimer's disease pathogenesis, as seen elsewhere
in the world. Aluminum is the most abundant metallic
element, comprising 5% of the earth's crust. For the
most part, aluminum is largely present ininsoluble, and
thus biologically unavailable, forms. Relatively little is
known about patterns oflong-term aluminum exposure
inpatients who eventually develop Alzheimer's disease.
Case-control studies have not detected anysignificantly
increased use of aluminum-containing antacids (41).
Data related to the tendency for subsequent develop-
ment of neurofibrillary tangles or outright Alzheimer's
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disease in individuals with industrial exposure to alu-
minum have not, to our knowledge, been published.
Despite its natural abundance, it is clear that alu-
minumcanbe apotentneurotoxin tocertainmammalian
species. The means by which the element gains access
to the tangle-bearing neurons seen in the brains ofAlz-
heimer's disease victims or of the affected Chamorro
natives currently remains unknown. Under normal con-
ditions, relatively little aluminum is absorbed by the
gastrointestinal system followingoral exposure (42) and
an extremely small amount ends up residing in nervous
system tissues. We assume that under conditions of
intraneuronal aluminum deposition some form ofblood-
brain barrier has been breached. We still do not know
if changes in factors such as aluminum speciation may
play an important role in ultimately determining neu-
ronal bioavailability of aluminum encountered in our
environment.
Considering the above, it is of interest, and perhaps
of some concern, that we note that one ofthe principle
effects ofacidrainis toleachlarge amounts ofaluminum
from the soil due to its lack of buffering capacity. Evi-
dence has been presented suggesting that an important
biologic effect of acid rain is to increase the bioavaila-
bilityofaluminumtobothfloraandfauna, withprofound
toxic effects. How high up the biologic ladder this con-
cept may extend can only be speculated upon.
It should be remembered that, although aluminum is
one ofthemostubiquitous elements in ourenvironment,
it has, until relatively recently, existed predominantly
in forms unavailable to man and most other biologic
species and is thus nontoxic. Accordingly, in an evolu-
tionary sense, little has been required, in terms ofnat-
ural barrier systems ordetoxifying mechanisms, to deal
with this substance. With the relatively recent appear-
ance ofacid rain, there has been a dramatic increase in
the amount of aluminum appearing in biologic ecosys-
tems with dramatically destructive effects on fish and
plant-life species. Itis clearthatthesespecies havebeen
unable to adapt successfully to these environmental
changes. Whether man will find himself in a similar
vulnerable state as regards changes in aluminum bioa-
vailability, can only be speculated upon. It is clear that
the potential magnitude ofthe problem requires urgent
further scientific study.
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